Plain-English translation of NCT04455282 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects blood samples and fluid from patients with esophageal cancer who are having surgery. Researchers are looking for special markers in your blood — called biomarkers — that might help doctors personalize your treatment plan and predict how you'll respond to surgery. The goal is to eventually use these biomarkers to give each patient the most appropriate care.
Doctors currently cannot easily predict which patients will have the best outcomes after esophageal cancer surgery, or which patients might develop cancer recurrence. By studying these biomarkers in your blood and lymphatic fluid, researchers hope to develop a test that can guide surgical decisions and help identify patients who need closer monitoring or additional treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have blood samples taken — some from your arm and some from veins near your tumor during surgery, plus fluid from your lymphatic system during the surgical procedure. After surgery, you'll have annual blood draws during routine follow-up visits, and additional samples if your cancer returns. Tissue removed during surgery that isn't needed for standard pathology will be stored for research. The study involves no additional procedures beyond what's already planned for your cancer care.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Germany